Dupixent (dupilumab) - Sanofi, Regeneron
Real-World 18-Month Dupilumab Effectiveness in Chronic Rhinosinusitis With Nasal Polyps and Coexisting Allergic Rhinitis: AROMA (ACAAI 2026) - Oct 28, 2026 - Abstract #R352; Pres time: Nov 14, 2026; 12:00 PM - 01:00 PM; Location: Phoenix Convention Center • North Halls 4–6 (Lower Level); Monitor 22; No abstract available 
Clinical • Real-world • Real-world evidence • Allergic Rhinitis • Chronic Rhinosinusitis With Nasal Polyps • Immunology • Inflammation • Nasal Polyps • Otorhinolaryngology • Respiratory Diseases • Sinusitis
https://annualmeeting.acaai.org/2026/submit_abstract.cfm
 
Oct 28, 2026
 
Prev Next